Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06506162 · ClinicalTrials.gov registry record · NA

Abuse Liability and Appeal of Oral Nicotine Products

A NA study of Nicotine Dependence, sponsored by University of Southern California.

Recruiting
Registry status
NA
Development phase
320
Enrollment target
2
Study locations

NCT06506162: Recruiting NA study of Nicotine Dependence, sponsored by University of Southern California.

NCT06506162 is a NA study of Nicotine Dependence that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 320 participants, above the 182-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (76% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06506162, a NA study of Nicotine Dependence, is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
NA
Development phase
320 participants
Enrollment target
2
Study locations

Study Summary

There has been a recent proliferation of novel oral nicotine products (ONPs) brought to market, including new nicotine gums and pouches. Unlike electronic cigarettes (ECs) ONPs have no impending regulatory barriers with regard to flavoring or nicotine dose, and manufacturers have capitalized on this by introducing an extensive slate of characterizing flavors and nicotine concentrations. Both sales trajectory and the surge in marketing suggest ONP use is likely to increase in the coming years. Work by the investigators and others indicates that interest in these products is high among current EC users, and among specific demographic groups including those who identify as sexual and gender minority (SGM). ONP use is discrete and so can function as a secondary source of nicotine, encouraging dual use patterns and more severe nicotine dependence. Depending on the use patterns of ONPs that emerge, regulation of ONPs may serve the public health interest. However, very little is known about factors relevant to the actual appeal and abuse liability of these products. The investigators propose to address this important gap by assessing the appeal and abuse liability of gum and pouch ONPs as a function of flavor (mint vs fruit) and nicotine concentration (2mg vs. 4mg). Flavor and nicotine strength, along with product type, are regulatable attributes, and so it is essential to understand their impact on appeal and abuse liability. Evidence from EC use suggests a potential interaction between flavor and nicotine strength, with flavorants in the "mint" category desensitizing receptors integral to the aversive sensory experience of nicotine, leading to greater tolerability of high nicotine concentration. Because of current ONP marketing emphasis on youth, the investigators will recruit young adult exclusive EC users (N = 320; ages 21 - 25). The investigators will target recruitment of a sufficient number of SGM participants (N = 64, 20% of sample) to allow assessment of potential

Primary Outcome

Participants will rate the sensory appeal of products and their motivation to use the products

Conditions Studied

Interventions

  • OTHER Flavor
  • OTHER Nicotine concentration

Study Locations (2)

California

  • University of Southern California - Los Angeles
  • University of Southern California - Los Angeles

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2024-02-09
Est. Completion 2028-02-14
Phase NA
University of Southern California

617 total trials

What NCT06506162 shows while recruiting

NCT06506162 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, above the 182-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (76% higher).

The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 2 interventions - of which Flavor is the first listed.

NCT06506162 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06506162 about?

NCT06506162 is a clinical study titled "Abuse Liability and Appeal of Oral Nicotine Products". There has been a recent proliferation of novel oral nicotine products (ONPs) brought to market, including new nicotine gums and pouches. Unlike electronic cigarettes (ECs) ONPs have no impending regulatory barriers with regard to flavoring or nicotine dose, and manufacturers have capitalized on this...

What is the current status of trial NCT06506162?

This trial is currently recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2024-02-09. Estimated completion is 2028-02-14.

What conditions does trial NCT06506162 study?

This clinical trial studies the following conditions: Nicotine Dependence.

What interventions are being tested in trial NCT06506162?

The interventions under investigation include: Flavor (OTHER), Nicotine concentration (OTHER).

Who is sponsoring clinical trial NCT06506162?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06506162 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nicotine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06506162's enrollment target sits among peer trials

320 13th of 67 higher than 55 of 67 other Nicotine Dependence trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Nicotine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02763683 · 320 participants

    Investigations of Dementia in Parkinson Disease

  • NCT03331198 · 320 participants · Phase 1

    Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

  • NCT03458832 · 320 participants

    Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

  • NCT03551951 · 320 participants

    Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06506162, the US trial registry maintained by the National Library of Medicine. NCT06506162 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.